Cargando…

FAT1 expression and mutations in adult acute lymphoblastic leukemia

Detalles Bibliográficos
Autores principales:	Neumann, M, Seehawer, M, Schlee, C, Vosberg, S, Heesch, S, von der Heide, E K, Graf, A, Krebs, S, Blum, H, Gökbuget, N, Schwartz, S, Hoelzer, D, Greif, P A, Baldus, C D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080215/ https://www.ncbi.nlm.nih.gov/pubmed/24972153 http://dx.doi.org/10.1038/bcj.2014.44

Ejemplares similares

Mutational spectrum of adult T-ALL
por: Neumann, Martin, et al.
Publicado: (2014)

Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients
por: Bartram, Isabelle, et al.
Publicado: (2014)

Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations
por: Neumann, M, et al.
Publicado: (2012)

FAT1 expression in T-cell acute lymphoblastic leukemia (T-ALL) modulates proliferation and WNT signaling
por: Liebig, Sven, et al.
Publicado: (2023)

Molecular characterization of TCF3::PBX1 chromosomal breakpoints in acute lymphoblastic leukemia and their use for measurable residual disease assessment
por: Burmeister, Thomas, et al.
Publicado: (2023)

FLT3 Mutations in Early T-Cell Precursor ALL Characterize a Stem Cell Like Leukemia and Imply the Clinical Use of Tyrosine Kinase Inhibitors
por: Neumann, Martin, et al.
Publicado: (2013)

Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemia
por: James, Alva Rani, et al.
Publicado: (2019)

Silencing of GATA3 defines a novel stem cell-like subgroup of ETP-ALL
por: Fransecky, L., et al.
Publicado: (2016)

Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures
por: Schroeder, Michael P., et al.
Publicado: (2019)

Clonal evolution of acute myeloid leukemia from diagnosis to relapse
por: Vosberg, Sebastian, et al.
Publicado: (2019)

Loss-of-function but not dominant-negative intragenic IKZF1 deletions are associated with an adverse prognosis in adult BCR-ABL-negative acute lymphoblastic leukemia
por: Kobitzsch, Benjamin, et al.
Publicado: (2017)

Fusion gene detection by RNA-sequencing complements diagnostics of acute myeloid leukemia and identifies recurring NRIP1-MIR99AHG rearrangements
por: Kerbs, Paul, et al.
Publicado: (2021)

Antileukemic activity of the HSP70 inhibitor pifithrin-μ in acute leukemia
por: Kaiser, M, et al.
Publicado: (2011)

Osteonecrosis in Adults With Acute Lymphoblastic Leukemia: An Unmet Clinical Need
por: Kuhlen, Michaela, et al.
Publicado: (2021)

Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia
por: Gökbuget, N, et al.
Publicado: (2016)

Inhibition of IGF1-R overcomes IGFBP7-induced chemotherapy resistance in T-ALL
por: Bartram, Isabelle, et al.
Publicado: (2015)

Dominant T-cell Receptor Delta Rearrangements in B-cell Precursor Acute Lymphoblastic Leukemia: Leukemic Markers or Physiological γδ T Repertoire?
por: Kelm, Miriam, et al.
Publicado: (2023)

Prognostic value of low-level MRD in adult acute lymphoblastic leukemia detected by low- and high-throughput methods
por: Kotrová, Michaela, et al.
Publicado: (2022)

Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia
por: Chitadze, Guranda, et al.
Publicado: (2023)

Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia
por: Zugmaier, G, et al.
Publicado: (2014)

General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemia
por: Gökbuget, Nicola, et al.
Publicado: (2023)

Inhibiting casein kinase 2 sensitizes acute lymphoblastic leukemia cells to venetoclax via MCL1 degradation
por: Lázaro-Navarro, Juan, et al.
Publicado: (2021)

Mutational landscape of adult ETP-ALL
por: Neumann, Martin, et al.
Publicado: (2013)

Young woman with mild bone marrow dysplasia, GATA2 and ASXL1 mutation treated with allogeneic hematopoietic stem cell transplantation
por: Lübking, Anna, et al.
Publicado: (2015)

Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia
por: Eldfors, S, et al.
Publicado: (2017)

Survival outcomes in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia treated with blinatumomab
por: Kantarjian, Hagop M., et al.
Publicado: (2023)

Long‐term survival of patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab
por: Topp, Max S., et al.
Publicado: (2020)

Targeting the leukemic bone marrow microenvironment
por: von der Heide, Eva Kristin, et al.
Publicado: (2017)

ERG induces a mesenchymal-like state associated with chemoresistance in leukemia cells
por: Mochmann, Liliana H., et al.
Publicado: (2013)

Efficacy of inotuzumab ozogamicin in patients with Philadelphia chromosome–positive relapsed/refractory acute lymphoblastic leukemia
por: Stock, Wendy, et al.
Publicado: (2020)

Switch to low-fat diet improves outcome of acute lymphoblastic leukemia in obese mice
por: Tucci, Jonathan, et al.
Publicado: (2018)

Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burden
por: DeAngelo, Daniel J., et al.
Publicado: (2020)

Nosocomial legionellosis and invasive aspergillosis in a child with T-lymphoblastic leukemia
por: Furtwängler, Rhoikos, et al.
Publicado: (2017)

The clinical mutatome of core binding factor leukemia
por: Opatz, Sabrina, et al.
Publicado: (2020)

Blinatumomab vs historic standard‐of‐care treatment for minimal residual disease in adults with B‐cell precursor acute lymphoblastic leukaemia
por: Gökbuget, Nicola, et al.
Publicado: (2020)

Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
por: Gibson, Amber, et al.
Publicado: (2021)

Tisagenlecleucel vs. historical standard of care in children and young adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
por: v. Stackelberg, Arend, et al.
Publicado: (2023)

ERG Transcriptional Networks in Primary Acute Leukemia Cells Implicate a Role for ERG in Deregulated Kinase Signaling
por: Bock, Juliane, et al.
Publicado: (2013)

Diplopia as the presenting feature of acute lymphoblastic leukemia
por: Burshina, A.T., et al.
Publicado: (2020)

Acute lymphoblastic leukemia
por: Schrappe, Martin
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o7ukjd8i7dc7jq8ssnd9rc8c7f